PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.560.02 (-0.36%)
5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Positive revenue growth while UPM.HE is negative. John Neff might see a notable competitive edge here.
16.80%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
19.63%
Positive EBIT growth while UPM.HE is negative. John Neff might see a substantial edge in operational management.
19.63%
Positive operating income growth while UPM.HE is negative. John Neff might view this as a competitive edge in operations.
18.73%
Positive net income growth while UPM.HE is negative. John Neff might see a big relative performance advantage.
21.43%
Positive EPS growth while UPM.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
21.43%
Positive diluted EPS growth while UPM.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-2.23%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.23%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
19.74%
Positive OCF growth while UPM.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
970.59%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-26.09%
Negative 10Y revenue/share CAGR while UPM.HE stands at 41.38%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.14%
5Y revenue/share CAGR under 50% of UPM.HE's 7.77%. Michael Burry would suspect a significant competitive gap or product weakness.
8.90%
3Y revenue/share CAGR at 75-90% of UPM.HE's 10.14%. Bill Ackman would expect new product strategies to close the gap.
591.58%
10Y OCF/share CAGR above 1.5x UPM.HE's 13.86%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
299.37%
5Y OCF/share CAGR above 1.5x UPM.HE's 20.35%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
258.96%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
148.99%
Net income/share CAGR at 50-75% of UPM.HE's 287.58%. Martin Whitman might question if the firm’s product or cost base lags behind.
150.10%
5Y net income/share CAGR above 1.5x UPM.HE's 56.39%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
142.86%
3Y net income/share CAGR above 1.5x UPM.HE's 33.97%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
53.48%
5Y equity/share CAGR above 1.5x UPM.HE's 32.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
25.43%
3Y equity/share CAGR similar to UPM.HE's 26.06%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Our AR growth while UPM.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.73%
Inventory growth well above UPM.HE's 3.42%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.40%
Negative asset growth while UPM.HE invests at 5.54%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
We have a declining book value while UPM.HE shows 2.59%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-11.02%
We’re deleveraging while UPM.HE stands at 63.35%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.89%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.